Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 3, 2001, Pages 1185-1192

  Mui, Barbara ^a   Raney, Sameersingh G ^a   Semple, Sean C ^a   Hope, Michael J ^a  

^a Inex Pharmaceuticals Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CANCER; CELL ACTIVATION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; IMMUNOGENICITY; IMMUNOSTIMULATION; INFECTION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CPG ISLANDS; CYTOKINES; DRUG CARRIERS; DRUG COMPOUNDING; INJECTIONS, INTRAVENOUS; LIPIDS; LIPOSOMES; MACROPHAGES; MICE; MICE, INBRED ICR; OLIGONUCLEOTIDES, ANTISENSE;

EID: 0034893986     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Spectrophotometric determination of phosphate esters in the presence and absence of orthophosphate
2. CpG-rich islands and the function of DNA methylation
3. A rapid method of total lipid extraction and purification
4. Characterization and modulation of immune stimulation by modified oligonucleotides
5. Intravenous administration of stabilized antisense lipid particles (SALP) leads to activation and expansion of liver natural killer cells
6. Targeting c-myc in leukemia
7. Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12
8. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice
9. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously
10. Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells
11. Antitumor effects of interleukin-12 in pre-clinical and early clinical studies
12. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
13. A toll-like receptor recognizes bacterial DNA
14. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential
15. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs
16. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA
17. Thermodynamics and structure of a DNA tetraplex: A spectroscopic and calorimetric study of the tetramolecular complexes of d(TG3T) and d(TG3T2G3T)
18. Liposomes and the reticuloendothelial system: Interactions of liposomes with macrophages and behaviour of liposomes in vivo
19. Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators
20. Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity
21. Contact hypersensitivity: A simple model for the characterization of disease-site targeting by liposomes
22. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
23. Phosphorothioate oligodeoxynucleotides: Antisense or anti-protein?
24. Mechanisms and therapeutic applications of immune stimulatory CpG DNA
25. CpG motifs in bacterial DNA trigger direct B-cell activation
26. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials
27. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice
28. Bacterial DNA as immune cell activator
29. Innate immune recognition: Mechanisms and pathways
30. Immune stimulation-a class effect of phosphorothioate oligodeoxynucleotides in rodents
31. Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells
32. Liposomes in chemo- and immunotherapy of cancer
33. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: Formation of novel small multilamellar vesicle structures
34. Lipid-based formulations of antisense oligonucleotides for systemic delivery applications
35. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligonucleotides
36. Conjugation of immunostimulatory DNA to the short ragweed allergen and a 1 enhances its immunogenicity and reduces its allergenicity
37. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms
38. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
39. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth
40. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis